Roanoke Asset Management Corp Edwards Lifesciences Corp Transaction History

Roanoke Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $240,760 - $277,450	3,060 New	3,060 $256,000
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $62,891 - $97,200	-1,200 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$47.89 - $64.05 $57,468 - $76,860	1,200 New	1,200 $230,000
Q4 2018 Feb 06, 2019	SELL	$46.41 - $56.94 $55,691 - $68,328	-1,200 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$45.7 - $58.03 $54,840 - $69,636	1,200 New	1,200 $209,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Roanoke Asset Management Corp with notifications on news.